Literature DB >> 23934698

Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.

William H Catherino1, Heba M Eltoukhi, Ayman Al-Hendy.   

Abstract

Uterine leiomyomas are the most common benign gynecologic condition. The prevalence is three times more common among women of African ethnicity. Disparity in this disease is evidenced by earlier age of onset, greater severity of symptoms, and different response to treatment. Although the pathogenesis of disease development is not completely known, growing evidence focuses on investigating the molecular mechanisms in disease development and the influence of ethnicity. Variation in the expression levels or function of estrogen and progesterone receptors, polymorphism of genes involved in estrogen synthesis and/or metabolism (COMT, CYP17), retinoic acid nuclear receptors (retinoid acid receptor-α, retinoid X receptor-α), and aberrant expression of micro-RNAs (miRNAs) are some of the molecular mechanisms that may be involved. Nutritional factors, such as vitamin D deficiency, might also contribute to the higher incidence in dark skinned populations who are also commonly suffer from hypovitaminosis D. Culture and environmental difference might have a role in disease development. Further analysis and better understanding of these mechanisms will provide insight into the molecular basis of racial disparities in leiomyoma formation and will help to develop new innovations in leiomyoma treatment. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23934698      PMCID: PMC4170830          DOI: 10.1055/s-0033-1348896

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  128 in total

1.  Cloning and expression of full-length cDNA encoding human vitamin D receptor.

Authors:  A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis.

Authors:  Po-Chin Huang; Eing-Mei Tsai; Wan-Fen Li; Pao-Chi Liao; Meng-Chu Chung; Ya-Hui Wang; Shu-Li Wang
Journal:  Hum Reprod       Date:  2010-02-10       Impact factor: 6.918

3.  Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.

Authors:  S D Gamage; E D Bischoff; K D Burroughs; W W Lamph; M M Gottardis; C L Walker; R Fuchs-Young
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

Review 4.  Renal fibrosis: new insights into the pathogenesis and therapeutics.

Authors:  Youhua Liu
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 5.  Abnormal gene expression in uterine leiomyomas.

Authors:  J Andersen; R L Barbieri
Journal:  J Soc Gynecol Investig       Date:  1995 Sep-Oct

6.  A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.

Authors:  Jiayin Wang; Noriyuki Ohara; Zhuo Wang; Wei Chen; Akira Morikawa; Hiroko Sasaki; Deborah A DeManno; Kristof Chwalisz; Takeshi Maruo
Journal:  Hum Reprod       Date:  2006-04-13       Impact factor: 6.918

7.  Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.

Authors:  Doina S Joseph; Minnie Malik; Sahadat Nurudeen; William H Catherino
Journal:  Fertil Steril       Date:  2009-03-27       Impact factor: 7.329

8.  Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells.

Authors:  Dong Zhang; Mohamed Al-Hendy; Gloria Richard-Davis; Valerie Montgomery-Rice; Veera Rajaratnam; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2009-10-12       Impact factor: 7.329

9.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Shanna Nesby-O'Dell; Kelley S Scanlon; Mary E Cogswell; Cathleen Gillespie; Bruce W Hollis; Anne C Looker; Chris Allen; Cindy Doughertly; Elaine W Gunter; Barbara A Bowman
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

10.  Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study.

Authors:  Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Hum Reprod       Date:  2004-06-24       Impact factor: 6.918

View more
  29 in total

1.  Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility.

Authors:  Aaron K Styer; Susan Jin; Dan Liu; Baisong Wang; Alex J Polotsky; Mindy S Christianson; Wendy Vitek; Lawrence Engmann; Karl Hansen; Robert Wild; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter Casson; Gregory M Christman; Alicia Christy; Michael P Diamond; Esther Eisenberg; Heping Zhang; Nanette Santoro
Journal:  Fertil Steril       Date:  2017-01-12       Impact factor: 7.329

Review 2.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

3.  Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.

Authors:  James A Simon; William Catherino; James H Segars; Rick E Blakesley; Anna Chan; Vilma Sniukiene; Ayman Al-Hendy
Journal:  Obstet Gynecol       Date:  2018-03       Impact factor: 7.661

Review 4.  Linking Race, Cancer Outcomes, and Tissue Repair.

Authors:  Jung S Byun; Samson Park; Ambar Caban; Alana Jones; Kevin Gardner
Journal:  Am J Pathol       Date:  2017-11-11       Impact factor: 4.307

Review 5.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

6.  Does elevated progesterone on day of oocyte maturation play a role in the racial disparities in IVF outcomes?

Authors:  Micah J Hill; G Donald Royster; Mansi Taneja; Mae Wu Healy; Shvetha M Zarek; Alicia Y Christy; Alan H DeCherney; Eric Widra; Kate Devine
Journal:  Reprod Biomed Online       Date:  2016-11-16       Impact factor: 3.828

Review 7.  Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids.

Authors:  Burkhard Helmke; Joern Bullerdiek; Carsten Holzmann; Wolfgang Kuepker; Birgit Rommel
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 8.  Cardiometabolic Risk Factors and Benign Gynecologic Disorders.

Authors:  Abdelrahman AlAshqar; Kristin Patzkowsky; Sadia Afrin; Robert Wild; Hugh S Taylor; Mostafa A Borahay
Journal:  Obstet Gynecol Surv       Date:  2019-11       Impact factor: 2.347

9.  Frequency of MED12 Mutation in Relation to Tumor and Patient's Clinical Characteristics: a Meta-analysis.

Authors:  Chao He; William Nelson; Hui Li; Ya-Dong Xu; Xue-Jiao Dai; Ying-Xiong Wang; Yu-Bin Ding; Yan-Ping Li; Tian Li
Journal:  Reprod Sci       Date:  2021-02-10       Impact factor: 3.060

Review 10.  The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids.

Authors:  Michał Ciebiera; Mohamed Ali; Lillian Prince; Stanisław Zgliczyński; Grzegorz Jakiel; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2020-10-27       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.